image
Healthcare - Medical - Care Facilities - NASDAQ - US
$ 1.59
-1.85 %
$ 158 M
Market Cap
-159.0
P/E
1. INTRINSIC VALUE

This DCF valuation model was last updated on Jun, 21, 2025.

The intrinsic value of one DCGO stock under the worst case scenario is HIDDEN Compared to the current market price of 1.59 USD, DocGo Inc. is HIDDEN

This DCF valuation model was last updated on Jun, 21, 2025.

The intrinsic value of one DCGO stock under the base case scenario is HIDDEN Compared to the current market price of 1.59 USD, DocGo Inc. is HIDDEN

This DCF valuation model was last updated on Jun, 21, 2025.

The intrinsic value of one DCGO stock under the best case scenario is HIDDEN Compared to the current market price of 1.59 USD, DocGo Inc. is HIDDEN

2. FUNDAMENTAL ANALYSIS

Price Chart DCGO

image
$6.0$6.0$5.5$5.5$5.0$5.0$4.5$4.5$4.0$4.0$3.5$3.5$3.0$3.0$2.5$2.5$2.0$2.0$1.5$1.5$1.0$1.0Jan '25Jan '2515 Jan15 JanFeb '25Feb '2515 Feb15 FebMar '25Mar '2515 Mar15 MarApr '25Apr '2515 Apr15 AprMay '25May '2515 May15 MayJun '25Jun '2515 Jun15 Jun
FINANCIALS
617 M REVENUE
-1.24%
28.7 M OPERATING INCOME
90.56%
13.4 M NET INCOME
94.80%
70.3 M OPERATING CASH FLOW
209.52%
-12.7 M INVESTING CASH FLOW
57.43%
-24.2 M FINANCING CASH FLOW
-2159.21%
96 M REVENUE
-20.52%
-14 M OPERATING INCOME
-87.30%
-11.1 M NET INCOME
-44.89%
9.66 M OPERATING CASH FLOW
-25.08%
-5.73 M INVESTING CASH FLOW
-2.90%
-8.52 M FINANCING CASH FLOW
-8.43%
Balance Sheet DocGo Inc.
image
Current Assets 304 M
Cash & Short-Term Investments 89.2 M
Receivables 211 M
Other Current Assets 4.34 M
Non-Current Assets 151 M
Long-Term Investments 5.55 M
PP&E 42.2 M
Other Non-Current Assets 103 M
19.59 %46.29 %9.26 %22.70 %Total Assets$455.6m
Current Liabilities 122 M
Accounts Payable 28.4 M
Short-Term Debt 38.6 M
Other Current Liabilities 54.9 M
Non-Current Liabilities 18.6 M
Long-Term Debt 18.6 M
Other Non-Current Liabilities 0
20.19 %27.45 %39.09 %13.27 %Total Liabilities$140.4m
EFFICIENCY
Earnings Waterfall DocGo Inc.
image
Revenue 617 M
Cost Of Revenue 403 M
Gross Profit 198 M
Operating Expenses 185 M
Operating Income 28.7 M
Other Expenses 15.3 M
Net Income 13.4 M
700m700m600m600m500m500m400m400m300m300m200m200m100m100m00617m(403m)198m(185m)29m(15m)13mRevenueRevenueCost Of RevenueCost Of RevenueGross ProfitGross ProfitOperating ExpensesOperating ExpensesOperating IncomeOperating IncomeOther ExpensesOther ExpensesNet IncomeNet Income
RATIOS
32.06% GROSS MARGIN
32.06%
4.65% OPERATING MARGIN
4.65%
3.24% NET MARGIN
3.24%
6.23% ROE
6.23%
4.39% ROA
4.39%
3.71% ROIC
3.71%
FREE CASH FLOW ANALYSIS
Free Cash Flow Analysis DocGo Inc.
image
80m80m60m60m40m40m20m20m00(20m)(20m)(40m)(40m)(60m)(60m)(80m)(80m)202020202021202120222022202320232024202420252025
Net Income 13.4 M
Depreciation & Amortization 15.9 M
Capital Expenditures -5.84 M
Stock-Based Compensation 13.6 M
Change in Working Capital 19.5 M
Others -30.3 M
Free Cash Flow 64.5 M
3. WALL STREET ANALYSTS ESTIMATES
Wall Street Analysts Price Targets DocGo Inc.
image
Wall Street analysts predict an average 1-year price target for DCGO of $6.78 , with forecasts ranging from a low of $2.85 to a high of $11 .
DCGO Lowest Price Target Wall Street Target
2.85 USD 79.25%
DCGO Average Price Target Wall Street Target
6.78 USD 326.62%
DCGO Highest Price Target Wall Street Target
11 USD 591.82%
Price
Max Price Target
Min Price Target
Average Price Target
11111010998877665544332211Aug '24Aug '24Oct '24Oct '24Nov '24Nov '2420252025Feb '25Feb '25Apr '25Apr '25Jun '25Jun '25Jul '25Jul '25Aug '25Aug '25Oct '25Oct '25Nov '25Nov '2520262026Feb '26Feb '26Apr '26Apr '26Jun '26Jun '26
4. DIVIDEND ANALYSIS
5. COMPETITION
slide 2 of 10
6. Ownership
Insider Ownership DocGo Inc.
image
Sold
0-3 MONTHS
0 USD 0
3-6 MONTHS
0 USD 0
6-9 MONTHS
174 K USD 2
9-12 MONTHS
0 USD 0
Bought
117 K USD 5
0-3 MONTHS
0 USD 0
3-6 MONTHS
0 USD 0
6-9 MONTHS
0 USD 0
9-12 MONTHS
7. News
DocGo Announces Upcoming Participation in the iAccess Alpha Virtual Best Ideas Summer Investment Conference 2025 NEW YORK--(BUSINESS WIRE)--DocGo Inc. (Nasdaq: DCGO) (“DocGo” or the “Company”), a leading provider of technology-enabled mobile health and medical transportation services, today announced that the Company will participate in the iAccess Alpha Virtual Best Ideas Summer Investment Conference 2025 on June 24 and 25, 2025. Representing the Company, CEO Lee Bienstock will deliver a presentation at 1:00 ET on Tuesday, June 24, followed by one-on-one meetings with investors on Wednesday, June 25. A w. businesswire.com - 1 week ago
DocGo Announces Upcoming Participation at the Goldman Sachs 46th Annual Global Healthcare Conference NEW YORK--(BUSINESS WIRE)--DocGo Inc. (Nasdaq: DCGO) (“DocGo”), a leading provider of technology-enabled mobile health and medical transportation services, today announced that Lee Bienstock, Chief Executive Officer, will participate in a fireside chat at the Goldman Sachs 46th Annual Global Healthcare Conference on Monday, June 9th from 4:00 – 4:35 PM Eastern Time, and hold 1x1 meetings as well. A webcast of the event will be available on the investor relations section of DocGo's website at ht. businesswire.com - 3 weeks ago
Kuehn Law Encourages Investors of DocGo, Inc. to Contact Law Firm NEW YORK, May 30, 2025 (GLOBE NEWSWIRE) -- Kuehn Law, PLLC, a shareholder litigation law firm, is investigating whether certain officers and directors of DocGo, Inc. (NASDAQ: DCGO) breached their fiduciary duties to shareholders. globenewswire.com - 4 weeks ago
Kuehn Law Encourages Investors of DocGo, Inc. to Contact Law Firm NEW YORK , May 29, 2025 /PRNewswire/ -- Kuehn Law, PLLC, a shareholder litigation law firm, is investigating whether certain officers and directors of DocGo, Inc. (NASDAQ: DCGO)  breached their fiduciary duties to shareholders.  According to a federal securities lawsuit, DocGo insiders caused the company to misrepresent or fail to disclose that (i) the processes DocGo used to hire executives were insufficient for thoroughly examining and verifying the professional and educational backgrounds of applicants; (ii) this inadequacy heightened the risk of disruptive changes in executive leadership; (iii) contrary to what it had communicated to investors, DocGo had overestimated the effectiveness of its mobile health and medical transportation services, which were key components of the Relocation Contract; (iv) all these issues, once disclosed, were likely to expose DocGo to considerable reputational and/or regulatory examination, adversely affecting the company's financial health and future outlook; and (v) consequently, the company's public declarations were inaccurate and misleading throughout the times in question. prnewswire.com - 4 weeks ago
DocGo Wins “Compliance Management Innovation Award” in 2025 MedTech Breakthrough Awards Program NEW YORK--(BUSINESS WIRE)--DocGo Inc. (Nasdaq: DCGO) (“DocGo”), a leading provider of technology-enabled mobile health services, today announced that it has been selected as winner of the “Compliance Management Innovation Award” in the 9th annual MedTech Breakthrough Awards program conducted by MedTech Breakthrough, an independent market intelligence organization that recognizes the top companies, technologies and products in the global digital health and medical technology market. DocGo's brea. businesswire.com - 1 month ago
DocGo, Inc (DCGO) Q1 2025 Earnings Call Transcript DocGo, Inc (NASDAQ:DCGO ) Q1 2025 Earnings Conference Call May 8, 2025 5:00 PM ET Company Participants Mike Cole - VP, IR Lee Bienstock - CEO Norman Rosenberg - CFO Conference Call Participants Ryan MacDonald - Needham Kieran Ryan - Deutsche Bank Jenny Shen - BTIG Operator Good afternoon, ladies and gentlemen, and welcome to the DocGo First Quarter Earnings Conference Call. At this time, all lines are in listen-only mode. seekingalpha.com - 1 month ago
DocGo Inc. (DCGO) Reports Q1 Loss, Misses Revenue Estimates DocGo Inc. (DCGO) came out with a quarterly loss of $0.09 per share versus the Zacks Consensus Estimate of a loss of $0.01. This compares to earnings of $0.09 per share a year ago. zacks.com - 1 month ago
DocGo Announces First Quarter 2025 Results NEW YORK--(BUSINESS WIRE)--DocGo Inc. (Nasdaq: DCGO) (“DocGo” or the “Company”), a leading provider of technology-enabled mobile health and medical transportation services, today announced financial and operating results for the quarter ended March 31, 2025. Lee Bienstock, Chief Executive Officer of DocGo, commented, “The impact of ongoing policy changes in Washington and adjustments to public spending on healthcare-related projects have created substantial uncertainty in our Government Populat. businesswire.com - 1 month ago
DOCGO INVESTIGATION CONTINUED by Former Louisiana Attorney General: Kahn Swick & Foti, LLC Continues to Investigate the Officers and Directors of DocGo Inc. - DCGO NEW YORK & NEW ORLEANS--(BUSINESS WIRE)--Former Attorney General of Louisiana, Charles C. Foti, Jr., Esq., a partner at the law firm of Kahn Swick & Foti, LLC (“KSF”), announces that KSF continues its investigation into DocGo Inc. (NasdaqCM: DCGO). DocGo is a healthcare company that provides medical transportation and mobile health services in the United States and the United Kingdom. In September 2023, news media sources reported numerous alleged misrepresentations by the Company, includin. businesswire.com - 1 month ago
DocGo to Announce First Quarter Results on Thursday, May 8, 2025 NEW YORK--(BUSINESS WIRE)--DocGo Inc. (Nasdaq: DCGO) (“DocGo” or the “Company”), a leading provider of technology-enabled mobile health services, announced today that the Company will release its financial results for the first quarter ended March 31st, 2025 after the markets close on Thursday, May 8th, 2025. Management will also host a conference call to discuss these results at 5:00 p.m. ET on that day. Conference call and webcast details: Thursday, May 8th, 2025 5:00 p.m. ET 1-800-717-1738 (. businesswire.com - 2 months ago
DOCGO INVESTIGATION CONTINUED BY FORMER LOUISIANA ATTORNEY GENERAL: Kahn Swick & Foti, LLC Continues to Investigate the Officers and Directors of DocGo Inc. - DCGO NEW YORK and NEW ORLEANS , April 18, 2025 /PRNewswire/ -- Former Attorney General of Louisiana, Charles C. Foti, Jr., Esq. prnewswire.com - 2 months ago
DOCGO INVESTIGATION CONTINUED by Former Louisiana Attorney General: Kahn Swick & Foti, LLC Continues to Investigate the Officers and Directors of DocGo Inc. - DCGO NEW YORK & NEW ORLEANS--(BUSINESS WIRE)--Former Attorney General of Louisiana, Charles C. Foti, Jr., Esq., a partner at the law firm of Kahn Swick & Foti, LLC (“KSF”), announces that KSF continues its investigation into DocGo Inc. (NasdaqCM: DCGO). DocGo is a healthcare company that provides medical transportation and mobile health services in the United States and the United Kingdom. In September 2023, news media sources reported numerous alleged misrepresentations by the Company, includin. businesswire.com - 2 months ago
8. Profile Summary

DocGo Inc. DCGO

image
COUNTRY US
INDUSTRY Medical - Care Facilities
MARKET CAP $ 158 M
Dividend Yield 0.00%
Description DocGo, Inc. provides mobile health and medical transportation services for various health care providers in the United States and the United Kingdom. The company's transportation services include emergency response services; and non-emergency transport services comprise ambulance and wheelchair transportation services. It also offers mobile health services through its platform that are performed at home and offices; COVID-19 testing; and event services, which include on-site healthcare support at sporting events and concerts. DocGo, Inc. was incorporated in 2015 and is headquartered in New York, New York.
Contact 35 West 35th Street, New York City, NY, 10001 https://www.docgo.com
IPO Date Dec. 17, 2020
Employees 3404
Officers Mr. Andre Oberholzer CPA Executive Vice President of Strategy Mr. Ely D. Tendler J.D. General Counsel, Secretary & Director Mr. Norman Rosenberg Treasurer & Chief Financial Officer Mr. Lee Bienstock Chief Executive Officer & Director Mr. Eiwe Lingefors Chief Information Officer Mr. Mike Cole Vice President of Investor Relations Ms. Rosemarie Milano Vice President of Human Resources Mr. Stephen Sugrue Chief Compliance Officer Dr. James Powell M.D. Chief Executive Officer of Clinical Practice Group & Member of Medical Advisory Board